Primoris (PRIM) director granted $37,500 in restricted stock compensation
Rhea-AI Filing Summary
Primoris Services Corp director Carla S. Mashinski received a stock grant as part of regular board compensation. On the reported date, she acquired 268 shares of common stock at no cash cost under the non-employee director compensation program.
The program targets a grant value of $37,500, calculated using the average closing price during March 2026, which determined the 268-share amount. After this award, she directly holds 22,092 shares. The granted shares cannot be sold for twelve months from the grant date.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 268 shares
Net Buy
1 txn
Insider
MASHINSKI CARLA S
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 268 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 22,092 shares (Direct)
Footnotes (1)
- F1. The non-employee director compensation program adopted by the Board in May 2011 and updated July 2024, provides for the issuance of restricted stock with a value of $37,500. The price per share was based on the average closing price during March 2026, resulting in a grant of 268 shares of stock. The shares of stock cannot be sold for a period of twelve months from the date of grant.
Key Figures
Stock grant size: 268 shares
Grant target value: $37,500
Shares after transaction: 22,092 shares
+2 more
5 metrics
Stock grant size
268 shares
Restricted stock award to director
Grant target value
$37,500
Non-employee director compensation program
Shares after transaction
22,092 shares
Director’s direct holdings following grant
Pricing reference period
March 2026 average closing price
Used to determine shares for the $37,500 grant
Sale restriction period
12 months
Granted shares cannot be sold for twelve months from grant
Key Terms
non-employee director compensation program, restricted stock, average closing price, grant of 268 shares, +1 more
5 terms
non-employee director compensation program financial
"The non-employee director compensation program adopted by the Board in May 2011 and updated July 2024..."
restricted stock financial
"provides for the issuance of restricted stock with a value of $37,500."
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
average closing price financial
"The price per share was based on the average closing price during March 2026..."
The average closing price is the arithmetic mean of a security’s end-of-day prices over a chosen period, found by adding each day’s closing price and dividing by the number of days. It smooths out daily ups and downs to show a typical market value—like averaging daily temperatures to understand a month’s climate—and helps investors spot trends, judge whether a stock is generally rising or falling, and make clearer buy or sell decisions.
cannot be sold for a period of twelve months regulatory
"The shares of stock cannot be sold for a period of twelve months from the date of grant."
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did Primoris (PRIM) director Carla Mashinski report in this Form 4?
Director Carla S. Mashinski reported receiving 268 shares of Primoris common stock as a grant. The award came under the company’s non-employee director compensation program and reflects stock-based compensation rather than an open-market purchase or sale.
How was the Primoris (PRIM) director stock grant value determined?
The stock grant to Carla Mashinski was set at a target value of $37,500. Primoris calculated the number of shares using the average closing price of its common stock during March 2026, resulting in an award of 268 shares.
Is this Primoris (PRIM) Form 4 transaction a market buy or sell?
This transaction is not a market buy or sell. It is an acquisition coded as a grant or award, where director Carla Mashinski received 268 shares as part of Primoris’s non-employee director compensation program, with no cash price per share reported.